EGFR and non-small cell lung carcinoma: Other authors used another approach to the concept of multifunctional nanoparticles, by using as an active targeting a synthetic luteinizing hormone-releasing hormone decapeptide onto NLC surface, to deliver directly to non-small cell lung carcinoma in mice, both paclitaxel and small interfering RNAs to suppress tyrosine kinase inhibitors acting on the epidermal growth factor receptors (EGFR-TK).